Radiofrequency ablation of medically inoperable stage IA non-small cell lung cancer: Are early posttreatment PET findings predictive of treatment outcome?

American Journal of Roentgenology

Volumn 197, Issue 2, 2011, Pages 334-340

  Yoo, Don C ^a   Dupuy, Damian E ^a   Hillman, Shauna L ^b   Fernando, Hiran C ^c   Rilling, William S ^d   Shepard, Jo Anne O ^e   Siegel, Barry A ^f  

^a RHODE ISLAND HOSPITAL   (United States)

^b MAYO CLINIC   (United States)

^c BOSTON UNIVERSITY MEDICAL CENTER   (United States)

^d MEDICAL COLLEGE OF WISCONSIN   (United States)

^e MASSACHUSETTS GENERAL HOSPITAL   (United States)

^f WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Non small cell lung cancer; PET CT; Radiofrequency ablation

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER STAGING; CLINICAL ARTICLE; COMPUTER ASSISTED EMISSION TOMOGRAPHY; CONTROLLED STUDY; DISEASE COURSE; DISEASE SEVERITY; FEMALE; HUMAN; LUNG NON SMALL CELL CANCER; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RADIOFREQUENCY ABLATION; THERMOCOAGULATION; TREATMENT OUTCOME;

AGED; AGED, 80 AND OVER; BIOPSY; CARCINOMA, NON-SMALL-CELL LUNG; CATHETER ABLATION; CONTRAST MEDIA; DISEASE PROGRESSION; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; POSITRON-EMISSION TOMOGRAPHY; PREDICTIVE VALUE OF TESTS; RADIOPHARMACEUTICALS; TREATMENT OUTCOME;

EID: 79960701078     PISSN: 0361803X     EISSN: 15463141     Source Type: Journal    
DOI: 10.2214/AJR.10.6108     Document Type: Article

References (19)

1. Dupuy DE, Zagoria RJ, Akerley W, et al. Percutaneous radiofrequency ablation of malignancies in the lung. AJR 2000; 174:57-59 (Pubitemid 30030208)
2. Goldberg SN, Dupuy DE. Image-guided radiofrequency tumor ablation: challenges and opportunities. Part 1. J Vasc Interv Radiol 2001; 12:1021-1032 (Pubitemid 32844849)
3. Gandhi NS, Dupuy DE. Image-guided radiofrequency ablation as a new treatment option for patients with lung cancer. Semin Roentgenol 2005; 40:171-181 (Pubitemid 40417895)
4. Fernando HC, De Hoyos A, Landreneau RJ, et al. Radiofrequency ablation for the treatment of nonsmall cell lung cancer in marginal surgical candidates. J Thorac Cardiovasc Surg 2005; 129:639-644 (Pubitemid 40311325)
5. Steinke K, Glenn D, King J, et al. Percutaneous imaging-guided radiofrequency ablation in patients with colorectal pulmonary metastases: 1-year follow-up. Ann Surg Oncol 2004; 11:207-212 (Pubitemid 40486798)
6. Suh R, Reckamp K, Zeidler M, Cameron R. Radiofrequency ablation in lung cancer: promising results in safety and efficacy. Oncology 2005; 19(suppl 4):12-21
7. Suh RD, Wallace AB, Sheehan RE, Heinze SB, Goldin JG. Unresectable pulmonary malignancies: CT-guided percutaneous radiofrequency ablation - preliminary results. Radiology 2003; 229: 821-829 (Pubitemid 37467589)
8. Akeboshi M, Yamakado K, Nakatsuka A, et al. Percutaneous radiofrequency ablation of lung neoplasms: initial therapeutic response. J Vasc Interv Radiol 2004; 15:463-470 (Pubitemid 38590870)
9. Okuma T, Okamura T, Matsuoka T, et al. Fluorine-18-fluorodeoxyglucose positron emission tomography for assessment of patients with unresectable recurrent or metastatic lung cancers after CT-guided radiofrequency ablation: preliminary results. Ann Nucl Med 2006; 20:115-121
10. Simon CJ, Dupuy DE, DiPetrillo TA, et al. Pulmonary radiofrequency ablation: long-term safety and efficacy in 153 patients. Radiology 2007; 243:268-275 (Pubitemid 46579719)
11. Dupuy DE, Goldberg SN. Image-guided radiofrequency tumor ablation: challenges and opportunities. Part 2. J Vasc Interv Radiol 2001; 12:1135-1148 (Pubitemid 32983350)
12. 18F-FDG small-animal PET for monitoring the therapeutic effect of CT-guided radiofrequency ablation on implanted VX2 lung tumors in rabbits. J Nucl Med 2006; 47:1351-1358
13. Liu ZY, Chang ZH, Lu ZM, et al. Early PET/CT after radiofrequency ablation in colorectal cancer liver metastases: is it useful? Chin Med J (Engl) 2010; 123:1690-1694
14. Boellaard R. Standards for PET image acquisition and quantitative data analysis. J Nucl Med 2009; 50(suppl 1):11S-20S
15. Patz EF Jr, Connolly J, Herndon J. Prognostic value of thoracic FDG PET imaging after treatment for non-small cell lung cancer. AJR 2000; 174:769-774 (Pubitemid 30126260)
16. Akhurst T, Downey RJ, Ginsberg MS, et al. An initial experience with FDG-PET in the imaging of residual disease after induction chemotherapy for lung cancer. Ann Thorac Surg 2002; 73:259-264
17. Kang S, Luo R, Liao W, Wu H, Zhang X, Meng Y. Single group study to evaluate the feasibility and complications of radiofrequency ablation and usefulness of post treatment position emission tomography in lung tumours. World J Surg Oncol 2004; 2:30
18. 18F-FDG PET/CT for the prediction and detection of local recurrence after radiofrequency ablation of malignant lung lesions. J Nucl Med 2010; 51:1833-1840
19. Deandreis D, Leboulleux S, Dromain C, et al. Role of FDG PET/CT and chest CT in the follow-up of lung lesions treated with radiofrequency ablation. Radiology 2011; 258:270-276